CPT 23100Surgery

Biopsy of shoulder joint

CPT code 23100 covers a surgical procedure where a doctor takes a tissue sample from inside the shoulder joint to test for disease, infection, or other abnormalities. This is an invasive diagnostic procedure typically performed when imaging and less invasive tests haven't provided a clear diagnosis.

Showing rates for

National Average

Base Medicare rate

$507.19

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

6.2

PE RVU (NF)

8.21

MP RVU

1.27

Total RVU

15.68

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Document the specific medical necessity for open or arthroscopic approach versus image-guided needle biopsy
Impact: Prevents downcoding to lower-paying needle biopsy codes (20610 at $98.67) - potential $408.52 loss per claim
Always append laterality modifiers (LT/RT) even though payment is identical for both facility and non-facility settings
Impact: Prevents automatic claim rejection; resubmission delays payment by 15-30 days on average
Submit pathology reports with the claim or have readily available for audits to prove tissue was actually obtained and analyzed
Impact: Reduces denial rate by approximately 35% and accelerates claim processing by 7-10 days
When performed with arthroscopy, separately document and code the biopsy only if distinct from routine synovial tissue sampling during diagnostic arthroscopy
Impact: Improper unbundling can trigger $507.19 takebacks plus potential fraud investigation; proper bundling prevents compliance risk
For Medicare patients, verify the procedure meets LCD/NCD requirements and obtain ABN if medical necessity may be questioned
Impact: ABN allows patient billing if Medicare denies; recovers full $507.19 versus complete write-off
Code to the highest level of specificity by documenting exact joint structures biopsied (synovium, cartilage, labrum) and approach method
Impact: Supports medical necessity and reduces audit vulnerability; practices with detailed documentation have 28% lower audit adjustment rates

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 23100?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT 23100 in 2025?

The 2025 Medicare national average reimbursement rate for CPT 23100 is $507.19 for both facility and non-facility settings. This is based on 15.68 total RVUs (6.2 work RVU, 8.21 PE RVU, 1.27 MP RVU) multiplied by the 2025 conversion factor of 32.3465. Actual payment may vary by geographic locality.

Can CPT 23100 be billed with shoulder arthroscopy codes?

CPT 23100 can be billed with arthroscopy codes (29805-29828) only when the biopsy represents a distinct diagnostic service beyond routine tissue sampling during arthroscopy. You must use modifier 59 or XU and document a separate lesion, different anatomical site, or distinct pathologic process. Most payers consider routine synovial sampling integral to diagnostic arthroscopy and will bundle without compelling documentation.

What is the difference between CPT 23100 and 23065/23066?

CPT 23100 is specifically for biopsy of the shoulder joint itself (intra-articular structures including synovium, cartilage, or joint capsule), while 23065 and 23066 are for soft tissue biopsies in the shoulder area (superficial and deep respectively) that do not involve entering the glenohumeral joint. The distinction is critical as 23100 reimburses at $507.19 versus lower rates for soft tissue codes.

Do I need to use modifier LT or RT when billing CPT 23100?

Yes, laterality modifiers LT (left) or RT (right) are required by most payers including Medicare when billing CPT 23100. While the reimbursement rate doesn't change based on side, omitting laterality modifiers will result in claim rejection or denial. This is a data quality requirement for all paired anatomical structures.

How many RVUs is CPT code 23100 worth?

CPT 23100 has a total of 15.68 RVUs in 2025, consisting of 6.2 work RVUs, 8.21 practice expense RVUs (both facility and non-facility), and 1.27 malpractice RVUs. This RVU value reflects the moderate complexity and surgical nature of shoulder joint biopsy procedures.

What documentation is required to support medical necessity for CPT 23100?

Documentation must include clinical indication for tissue diagnosis, results of prior diagnostic workup (imaging, lab tests, physical exam findings), explanation of why less invasive methods are insufficient, operative note confirming intra-articular access and tissue collection, and pathology report. Many payers require evidence that image-guided needle biopsy was attempted, contraindicated, or inadequate for the suspected pathology.

Is CPT 23100 performed as an inpatient or outpatient procedure?

CPT 23100 can be performed in either inpatient or outpatient settings, though it's most commonly done as an outpatient procedure in ASCs or hospital outpatient departments. The Medicare reimbursement rate is identical ($507.19) for both facility and non-facility settings. The setting choice depends on patient complexity, comorbidities, and suspected diagnosis (infection cases may require inpatient admission).